Skip to content

Latest commit

 

History

History
30 lines (17 loc) · 2.06 KB

File metadata and controls

30 lines (17 loc) · 2.06 KB

Incentive model and awards

To incentivize wardens, C4 uses a unique scoring system with two primary goals: reward contestants for finding unique bugs and also to make the contest resistant to Sybil attack. A secondary goal of the scoring system is to encourage contestants to form teams and collaborate.

Judges are incentivized to review findings and decide their severity, validity, and quality by receiving a share of the prize pool themselves.

High and Medium Risk bugs

Contestants are given shares for bugs discovered based on severity, and those shares give the owner a pro rata piece of the pot:

Med Risk Shares: 3 * (0.9 ^ (findingCount - 1)) / findingCount
High Risk Shares: 10 * (0.9 ^ (findingCount - 1)) / findingCount

During awarding, each share is redeemed for: pot / number of shares.

QA and Gas Optimization Reports

In order to incentivize wardens to focus efforts on high and medium severity findings while also ensuring quality coverage, the pool’s allocation is capped for low severity, non-critical, and gas optimization findings.

Low and non-critical findings are submitted as a single QA report. Similarly, gas optimizations are submitted as a single gas report. For more on reports, see Judging criteria.

QA and gas optimization reports are awarded on a curve based on the judge’s score.

  • QA reports compete for a share of 10% of the prize pool (e.g. $5,000 for a $50,000 contest);
  • The gas optimization pool varies from contest to contest, but is typically 5% of the total prize pool (e.g. $2,500 for a $50,000 contest);
  • QA and Gas optimization reports are scored by judges on a 100 point scale and awarded on a curve.

Note: Contests pre-dating February 3, 2022 awarded low risk and gas optimization shares as: Low Risk Shares: 1 * (0.9 ^ (findingCount - 1)) / findingCount

Historically, Code4rena valued non-critical findings at 0; the intent of the QA report is not to increase the value of non-criticals, but rather to allow them to be consolidated in reports alongside low severity issues.